Want to join the conversation?
$Z 2Q15 Call: Resulting in a GAAP net loss of $38.7MM in the second quarter of 2015, which includes the impact of $1.7MM of acquisition-related costs and $6.7MM of restructuring costs due to the company's February 2015 acquisition of Trulia and the related restructuring plan.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.